4 Oct 2016
Clariant turns spotlight on high-purity pharma ingredients at CPhI Worldwide 2016
- Effective & efficient PEGs supported by DMFs & CEP certification
- Reliable partner to the pharmaceutical industry
- Meet the team at Hall 4 Booth 4J46 from October 4-6 in Barcelona
Muttenz, October 4, 2016 – Clariant, a world leader in specialty chemicals, is featuring its universally applicable high-purity PEGs at a booth dedicated to the specific needs of pharmaceutical formulators at this year’s CPhI Worldwide in Barcelona, October 4-6, 2016.
Clariant’s high-purity Polyglykol pharmaceutical polymers are highly water soluble with outstanding toxicological safety. They provide consistent and trusted performance in a wide range of applications, whether acting for example as excipients in suppositories, tablets, liquids or ointment bases, as actives in laxatives or for organ preservation, or as reaction compounds for drug delivery systems.
Experts from Clariant’s Business Unit Industrial & Consumer Specialties will be on-hand throughout CPhI to present the benefits of its PEGs alongside a complete range of Macrogols with various molecular weights, all of them supported by CEP certification and DMFs.
The pharmaceutical market has very specific requirements for high-purity ingredients that can enable it to more easily and sustainably develop today’s healthcare innovations. This is an area where Clariant, with its universally applicable PEGs, is valued as a reliable partner.
For more information on Polyglykols visit Clariant at CPhI Hall 4, Stand 4J46. Clariant will also showcase solutions for the healthcare packaging segment at Hall 2 Booth 2K60.
Reader enquiries
Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland
Notes for editors
Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On 31 December 2015 the company employed a total workforce of 17 213. In the financial year 2015, Clariant recorded sales of CHF 5.807 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. Clariant’s corporate strategy is based on five pillars: focus on innovation through R&D, add value with sustainability, reposition portfolio, intensify growth, and increase profitability.
Related images
Clariant turns spotlight on high-purity pharma ingredients at CPhI Worldwide 2016.
(Photo: Clariant)
Editorial enquiries
Stefanie Nehlsen
Clariant International Ltd
stefanie.nehlsen@clariant.com
Josina van der Velden
EMG